The FDA first made Paxlovid available under emergency use authorization. The new decision means there is extensive data showing the drug is safe and effective.
WASHINGTON — Pfizer received full approval on Thursday for its covid-19 pill Paxlovid that’s been the go-to treatment against the coronavirus. More than 11 million prescriptions for Paxlovid have been dispensed since the Food and Drug Administration allowed emergency use in late 2021.
The US Food and Drug Administration on Thursday fully approved the antiviral medication Paxlovid to treat mild-to-moderate Covid-19 in adults at risk for severe infections.
THURSDAY, May 25, 2023 (HealthDay News) -- Americans with COVID-19 have been taking Paxlovid since it was approved under emergency use in late 2021. Today, the U.S. Food and Drug
Thursday's action means the drug has now been fully vetted by the U.S. government and can remain on the market indefinitely. Millions of Americans have received Paxlovid since it was granted emergency authorization in late 2021.
Identical headlines usually mean shared wire copy. They are counted as separate articles but are not independent confirmation.
COVID pill Paxlovid gets full FDA approval after more than a year of emergency use | Since Then
